Glue42 Desktop Enterprise Edition Trial Terms and Conditions

     Last updated September 5, 2018

 

Thank you for choosing Glue42

The Glue42 Desktop Enterprise software (“Software”) is provided by Tick42 OOD (a Bulgarian registered company – “Tick42”). By using our Software, you are agreeing to these Terms of Use (“Terms”). If you are using the Software on behalf of an organization or entity (“Organization”), then you are agreeing to these Terms on behalf of the Organization. In that case, “you” and “your” may refer to the Organization. Please read these Terms carefully before you start using our Software.

Trial Grant

Subject to the Terms and conditions set forth, Tick42 grants to the Organization and the Organization accepts a royalty-free, time-limited license, solely for non-production, internal test and demonstration purposes (the “Trial”).

The initial term of this license (“Trial-Period”) is 30-days from date of first installation; this can be extended by mutual agreement.

Trial Restrictions

You may not sub-license, distribute, publish, transfer, rent, lease or otherwise make available the Trial to any third parties. To the fullest extent permitted by applicable law, you may not disassemble, decompile or “unlock”, decode or otherwise reverse translate or engineer, or attempt in any manner to reconstruct or discover any source code or underlying algorithms of the Trial that is provided to you in object code form only. Under no circumstances may any portion of the Trial’s source code or any modified version of the source code be distributed, disclosed or otherwise made available to any third party.

You may not circumvent any technical limitations included in the Trial for example time limited licences. You may not use the Trial as a whole, or any of its components, as a basis for creation of another software product that has the same or similar functionality as the Software.

Changes to the Terms of Use

From time to time, Tick42 may modify existing Terms and/or update these Terms with additional terms that apply to the Trial. You should stop using the Trial if you don’t accept the changes.

Using Our Trial

You must follow any policies made available to you within the Trial. You may only use our Trial as permitted by law. Tick42 may investigate and/or suspend or terminate your Trial at any time if we find your use of our Software violates the Terms and/or any policies.

Using our Trial does not grant you ownership of any intellectual property rights in our Trial or the content you may have access to. The Terms do not grant you the right to use any branding or logos used in our Trial. Our Trial may display some logos, trademarks, or branding materials that is not the property of Tick42. These types of content are the sole responsibility of the entity that makes it available.

You must not abuse and/or misuse our Trial, including but not limited to, doing the following things:

  • Using the Trial for any unlawful purposes or activities;
  • Uploading any content in violation of any applicable law, including but not limited to, intellectual property laws and publicity laws;
  • Accessing or tampering with the Trial’s server systems;

Tick42, at its sole discretion, will determine abuse and/or misuse of our Trial.

Limited Liability for our Trial

The Trial is available “as is”. You expressly understand and agree that:
Tick42 and its partners, licensors employees and agents will not be responsible for any lost profits, revenues, other financial losses or data under any circumstances.
Your use of the Trial is at your sole risk.
You will not access the Sites or use the Trial to collect any market research for a competing business.

Tick42 does not warrant that:

The Trial will meet all of your requirements at all times.
The Trial will be error-free and all errors in the Software will be corrected

Support

During the trial period you will have access to developer documentation, knowledge base articles and tutorials.

Termination

At the end of the Trial-Period, you must permanently delete all copies of the Software.